PEMF Studies

We’ve analysed a wide range of PEMF studies across different conditions and organised them into intensity brackets to make them easier to navigate. While intensity is commonly reported in research, it’s just one part of the picture. Wherever possible, we’ve included the full settings used in each study.

Low Intensity Studies (0-10 Gauss)

ATP - Cellular Energy Production

You may have heard the saying that the mitochondria is the powerhouse of the cell, and that's because they are major generators of ATP (adenosine triphosphate), a key molecule in energy storage and transfer in living organisms. One of the most significant applications of PEMFs is enhancing the utilization and production of ATP, thereby boosting energy levels in the body's tissues.

To understand how this works, we first need to grasp ATP hydrolysis, the process by which ATP is broken down into ADP (adenosine diphosphate) to release energy. The enzyme responsible for this task is ATPase, which can be found in mitochondria.

When ATPase was exposed to 60 Hz PEMF and different intensities of 3 gauss and 5 gauss this enhanced the hydrolysis activity, whereas 1 gauss exposure caused no significant changes. So, in addition to helping with ATP synthesis, PEMFs increase the production of energy from the ATP itself, but only if the stimulation is above a specific intensity threshold.

PubMed ID: 19496105

PEMF Safety - Implant Heating

This study looked at electromagnetic stimulation for fracture healing and whether it caused any meaningful heating in bone-like tissue or metallic implants. The field at the fracture site was relatively low, approximately 0.5–2 gauss, applied at 10 kHz.

The main finding was that the tissue-like tibia phantom showed almost no heating, while the metal implant warmed slightly because of induced eddy currents. The implant temperature increased by around 0.4–0.45 °C before stabilising, whereas the surrounding bone-like material changed by only about 0.05 °C, which was considered negligible.

Overall, this was a safety-focused study showing that the electromagnetic stimulation produced minimal thermal effects in tissue, with only a small and controlled temperature rise in metallic implants.

PubMed ID: 41899895

Wound Healing - Cell Proliferation & Migration

This study looked at how low-frequency pulsed electromagnetic fields (PEMFs) may support wound healing, particularly during a key phase of skin repair. The researchers tested this on human skin cells called dermal fibroblasts (HDFs), which play an important role in closing wounds. The cells were exposed to PEMF frequencies of 10–12 Hz and 100 Hz, using a very low-intensity, non-uniform magnetic field ranging from around 0.01–1.5 gauss, with the highest intensity directly above the coils.

They found that 10–12 Hz PEMF increased the expression of a gene linked to cell growth, suggesting it may help skin cells proliferate. When exposed to 100 Hz PEMF, the cells moved more quickly into the wound area, and internal structures called actin fibres began organising earlier, which is associated with cell movement. Both frequencies also helped the cells mature into myofibroblasts, which are important for wound contraction and closure.

Overall, this study suggests that low-intensity PEMF therapy could help support skin healing by encouraging skin cells to grow, migrate, and mature more efficiently.

PubMed ID: 38807301

Medium Intensity Studies (10-100 Gauss)

Back Pain

The study aimed to investigate whether PEMF therapy could provide additional benefits for people with chronic low back pain compared to traditional physical therapy alone. Conducted at a clinic in Cairo, Egypt, from May 2015 to September 2016, the study involved 50 participants with chronic low back pain. These participants were randomly divided into two groups: the experimental group, which received regular physical therapy plus real PEMF therapy (50Hz frequency, 20 Gauss intensity), and the control group, which received regular physical therapy plus a fake (sham) PEMF therapy. Both groups underwent 12 treatment sessions over four weeks.

The study measured pain levels, disability due to back pain, and the range of motion (ROM) of the lower back. The results showed that the group receiving PEMF therapy experienced significantly less pain and disability and had better lower back movement in all directions (forward, backward, and side to side) compared to the control group. In conclusion, adding PEMF therapy to regular physical therapy resulted in superior improvements in pain relief, daily function, and back movement for patients with chronic low back pain. This suggests that PEMF therapy could be a valuable addition to traditional treatments for chronic low back pain.

PubMed ID: 30177406

Blood Vessels Formation - Angiogenesis

This study examines how PEMFs affect the growth of new blood vessels in human endothelial cells (HUVECs), a process called angiogenesis, which is crucial for healing damaged tissues.

Researchers discovered that exposure to PEMFs with a peak intensity of 40 Gauss and a frequency of 80 Hz enhanced the cells' ability to grow and form new blood vessels by changing how the cells produce energy. Instead of relying on their usual energy production method, which can create harmful by products called reactive oxygen species (ROS), the cells switched to a faster and cleaner energy production process known as glycolysis.

This switch not only provided the cells with more energy but also created a healthier environment for cell growth. The study also found that this change in energy production was linked to changes in the cells' mitochondria, the parts of the cell that generate energy. Specifically, the mitochondria underwent a process called fission, which helps the cell maintain its energy needs and overall health.

Study link: click here

Bone Regeneration - Stem Cell Activity

This study looked at how pulsed electromagnetic fields (PEMF) influence stem cells involved in bone formation. The researchers focused on human adipose-derived stem cells (hASCs), which are found in fat tissue and can develop into different cell types, including bone cells. The cells were exposed to PEMF at a frequency of 50 Hz and an intensity of 10 gauss for 2 hours per day.

They found that PEMF increased cell proliferation in the early stages, meaning the stem cells multiplied more quickly. Over time, PEMF also promoted osteogenic differentiation, which is the process of these stem cells turning into bone-forming cells. This was shown through increased activity in bone-related markers and genes, as well as higher levels of proteins associated with bone formation.

Overall, this study suggests that moderate-intensity PEMF may support both the growth and development of stem cells into bone tissue, highlighting its potential role in bone repair and regeneration.

PubMed ID: 29775452

Bone Health - Type 2 Diabetes

Over 12 weeks, mice exposed to PEMF at a frequency of 15 Hz and intensity of 20 Gauss showed significant improvements in both the spongy inner layer (cancellous bone) and the dense outer layer (cortical bone), as evidenced by X-ray imaging.

Additionally, PEMF treatment led to increased bone formation, indicated by higher bone formation activity and faster addition of new bone minerals to existing bone, without affecting the process of bone resorption (the breakdown of bone tissue and release of minerals like calcium into the bloodstream). Gene expression analysis showed that PEMF increased the activity of genes related to bone formation through Wnt/β-catenin signaling but did not affect the signaling involved in osteoclastogenesis (bone breakdown).

PubMed ID: 28883516

Neuronal Maturation - Synaptic Development

This study looked at how PEMF may support neuronal maturation, using human induced pluripotent stem cell-derived cortical neurons. The cells were exposed to PEMF at an intensity of 10 gauss, a frequency of 15 Hz, and a 3.75 ms pulse duration for 2 hours per day over 7 days. The researchers used a custom Helmholtz coil system to provide a uniform field across the central exposure region.

They found that PEMF helped the neurons mature more quickly in the early stages. While it did not significantly increase neurite outgrowth, it did increase markers linked to neuronal differentiation and synaptic maturation. PEMF-treated neurons also showed stronger spontaneous calcium signalling, improved excitability, and better action potential properties, suggesting the cells were becoming more functionally mature.

The study also identified a possible mechanism behind these effects. PEMF upregulated genes involved in cholesterol biosynthesis, especially FDFT1, a key enzyme in that pathway. When FDFT1 was blocked or knocked down, the PEMF-related gains in neuronal differentiation and synaptic development disappeared, suggesting that this cholesterol pathway was central to the response.

Overall, this study suggests that moderate-intensity PEMF may help immature neurons develop more efficiently by supporting early neuronal differentiation, synaptic development, and functional maturation, rather than simply increasing cell growth or neurite length.

PubMed: 40713855

Osteoporosis - PEMF vs Alendronate

In a study on postmenopausal osteoporosis (PMO) in southwest China, 44 women were randomly assigned to either alendronate, a commonly used medication for treating postmenopausal osteoporosis, or PEMF treatment.

The main goal was to see how these treatments affected bone density in the spine and hip, as well as vitamin D levels, muscle strength, and balance over 24 weeks.

Results showed no significant difference between the two groups in improving bone density, muscle strength, balance, and vitamin D levels. This suggests that PEMF treatment is as effective as the commonly used medication alendronate for PMO over the 24-week period.

PubMed ID: 23362148

PTSD

This study explored whether PEMF therapy could reduce PTSD-like behaviours and promote brain cell growth in rats.

The rats were divided into groups: some were exposed to PTSD stress, and some weren't, with some receiving PEMF treatment and others not. The PTSD rats treated with PEMF received daily sessions for 14 days, with each session lasting 16 minutes at a frequency of 30 Hz and intensity of 70 gauss.

The results showed that these PTSD rats had less fear and anxiety, and improved brain cell growth, compared to those that didn’t receive PEMF. This suggests PEMF might help reduce PTSD symptoms and protect brain health.

PubMed ID: 6570745

Reduced Inflammation

In chronic inflammatory conditions such as rheumatoid arthritis, inflammatory bowel disease, and asthma, pro-inflammatory cytokines are continuously released. These cytokines fuel inflammation, contributing to tissue damage and disease progression. They play a central role in driving the inflammatory process characteristic of these conditions, leading to symptoms such as pain, swelling, and tissue dysfunction.

One study used 15 gauss PEMFs at 75 Hz, and it was observed to increase A2A (adenosine receptors) and ARs (androgens) within the body. This is associated with a significant inhibition of the pro-inflammatory signalling pathway (NF-kB), leading to a decrease in both the synthesis and activation of pro-inflammatory cytokines.

The anti-inflammatory and tissue-preserving effects exerted by PEMFs through the specific action on A2A and ARs show great potential to be exploited also to control brain inflammation and to provide neuroprotection following brain damage.

Science Direct ID: S1094715921064266

Refractory Migraines

In this placebo-controlled study they investigate the effect of PEMF therapy on refractory migraines, which is a type of migraine that does not respond to typical migraine treatments.

They used 10 Hz PEMFs at 40-50 gauss intensity and they saw a significant improvement for the active group in terms of their headache days, durations and work-loss hours due to headache compared to the placebo group after 2 weeks.

The added results of the assessment of the active group indicated a significant improvement in the days and duration of headaches, work-loss hours and number of medications even after a following 4-8-month period.

International Journal of Clinical Trials: Study link

Skin Wound Healing

This study developed a model to test localised electromagnetic stimulation on full-thickness skin wounds, using a flexible copper coil patch applied directly over the wound area. Parameters were optimised beforehand, with the final setup using 13 gauss at 30 Hz for 60 minutes per day.

The key finding was that this targeted, localised approach supported improved healing, with treated wounds showing better progression compared to untreated controls. The study also highlighted how adjusting intensity, frequency, and duration can directly influence outcomes, with higher-end parameters (within the tested range) driving stronger fibroblast activity.

Overall, this reinforces the idea that local application and correct parameter selection are critical when using electromagnetic stimulation for tissue repair.

PubMed: 41838589

High Intensity Studies (100-1000 Gauss)

Breast Cancer

The currently available anti-cancer therapies, such as gamma radiation and chemotherapeutic agents, induce cell death and cellular senescence (a state in which a cell stops dividing) not only in cancer cells but also in the adjacent normal tissue.

They studied how breast cancer cells (MCF-7 and MDA-MB-231) and normal cells found in connective tissue (fibroblasts - FF95) reacted to PEMFs.

PEMFs were applied at a frequency of 8 Hz, intensity of 110 gauss, using a square wave, and applied twice daily for 5 days.

The data collected showed that the application of PEMF decreases the proliferation rate (how quickly cells multiply or reproduce) and viability (their ability to survive and function normally) of breast cancer cells while having the opposite effect on normal fibroblasts. Additionally, PEMF induces cell death and cellular senescence only in breast cancer cells without any effect on the non-cancerous cells.

PubMed ID: 38473720

Super High Intensity Studies (1000+ Gauss)

Cell Permeability - DNA Uptake

This study looked at whether high-intensity pulsed electromagnetic fields (HI-PEMF) could be used to deliver plasmid DNA into cells in vitro. The intensity was extremely high, with a magnetic field of 67,000 Gauss at the centre of the coil, and an induced electric field of up to 20 V/cm near the windings.

The researchers found that HI-PEMF did enable gene electrotransfection, meaning it helped plasmid DNA interact with the cell membrane and enter cells, leading to green fluorescent protein expression. It also appeared to support the uptake of larger molecules, suggesting endocytosis may be one of the uptake mechanisms.

Overall, this was a positive proof-of-concept study, showing that very high-intensity PEMF can achieve non-contact gene delivery, although it was still much less efficient than conventional electroporation.

PubMed ID: 36076938

Chronic Pain - HRV Changes

This study looked at a single session of high-intensity PEMF (PAPIMI) on people with chronic musculoskeletal pain. The device delivered pulses at around 500–1,500 gauss with a repetition rate of 2.5 Hz.

They found a significant reduction in pain immediately after treatment, alongside increases in heart rate variability (HRV) markers linked to parasympathetic activity. This suggests both pain relief and a shift toward a more relaxed autonomic state.

Overall, this was a positive result, showing that even one session of high-intensity PEMF may have rapid, short-term effects on pain and systemic regulation, although it’s a small pilot study with no control group.

PubMed ID: 40868622

Immune Response & Cellular Stress (DAMP Release)

In this study, researchers looked at how different cell types responded to very high-intensity PEMF, specifically measuring the release of DAMP molecules, which are typically released when cells are stressed or damaged and can trigger an immune response.

They applied HI-PEMF using short pulses (20 microseconds) at around 67,000 gauss, delivered in 350 pulses at 1 Hz, with conditions set to keep most cells alive (~90%).

What they found was that there was a small, immediate release of ATP after treatment, suggesting the cell membrane became temporarily more permeable. However, there was no significant release of other key stress signals (like calreticulin or HMGB1), which are usually linked to a stronger immune response.

This suggests that even at very high intensities, HI-PEMF can influence the cell membrane and allow things to move in and out, without triggering a strong immune reaction or causing significant cell damage. In simple terms, it’s more of a temporary change in cell behaviour, rather than a full stress or damage response, showing how different settings can lead to very different biological effects.

PubMed ID: PMC10572873

Unspecified Intensity Studies

Brain Health & Traumatic Brain Injuries

This study explored if PEMF could help the brain, especially after injuries like strokes or traumatic brain injuries, by improving blood flow and oxygen levels in brain tissue.

PEMF treatment caused the brain's small blood vessels (arterioles) to widen from an average of 26.4 micrometers to 29.1 micrometers, which increased blood flow through the capillaries and sped up red blood cell movement by about 5.5%. This enhanced blood flow improved oxygenation in the brain tissue, as indicated by a specific decrease in a marker (NADH fluorescence). When nitric oxide (NO) production was blocked, these effects did not occur, showing that NO is crucial for PEMF's impact.

This study is the first to demonstrate that PEMF can rapidly enhance blood flow and oxygen levels in the brain's small blood vessels, with benefits lasting at least three hours after just 30 minutes of treatment. These improvements were driven by an increase in nitric oxide, suggesting that PEMF could be a valuable treatment for improving brain health following injuries like strokes or trauma.

PubMed ID: 25343187

Blood Vessels Expansion - Vasodilation

This study looked at how pulsed electromagnetic fields affect small blood vessels in rats. The researchers thought that PEMF might help these blood vessels expand, which could be part of how it helps heal injuries.

In the experiment, rats were given either PEMF or a fake treatment for 2 or 60 minutes. The size of their blood vessels was measured before and after the treatments. The results showed that PEMF made the blood vessels expand significantly, with a 9% increase in size after 2 minutes and an 8.7% increase after 60 minutes. The rats that got the fake treatment didn't show any changes in their blood vessels. PEMF didn't affect blood pressure, heart rate, or tissue temperature.

These results suggest that PEMF can make blood vessels expand, which might be a reason why it's effective in healing. This effect was not due to changes in overall blood pressure or temperature.

PubMed ID: 14656663

Blood Vessels Formation - Angiogenesis

This study examines how PEMFs affect the growth of new blood vessels in human endothelial cells (HUVECs), a process called angiogenesis, which is crucial for healing damaged tissues.

Researchers discovered that exposure to PEMFs with a peak intensity of 40 Gauss and a frequency of 80 Hz enhanced the cells' ability to grow and form new blood vessels by changing how the cells produce energy. Instead of relying on their usual energy production method, which can create harmful by products called reactive oxygen species (ROS), the cells switched to a faster and cleaner energy production process known as glycolysis.

This switch not only provided the cells with more energy but also created a healthier environment for cell growth. The study also found that this change in energy production was linked to changes in the cells' mitochondria, the parts of the cell that generate energy. Specifically, the mitochondria underwent a process called fission, which helps the cell maintain its energy needs and overall health.

Study link: click here

Cancer Cells - Stemness Reduction

This study looked at how electromagnetic stimulation affects glioblastoma (brain cancer) cells, particularly their ability to behave like stem cells and resist treatment. The protocol used a low-frequency PEMF, but the exact intensity wasn’t specified in the abstract (described as a defined low-frequency exposure, typically within therapeutic ranges).

The key finding was that stimulation reduced “stemness” meaning the cancer cells became less aggressive and less able to regenerate. This was shown by decreased expression of stem cell markers and reduced formation of neurospheres (a sign of tumour growth potential).

Importantly, PEMF also enhanced the effect of chemotherapy (temozolomide), increasing cancer cell death. On its own, the effect on viability was modest, but in combination with treatment, the impact was much stronger.

Overall, this suggests electromagnetic stimulation may help make aggressive cancer cells more treatable, not by killing them directly, but by reducing their resistance and improving drug response.

Nature: s41598-026-47481-y

Cartilage Repair

The research showed that PEMF stimulates chondrocytes (cartilage cells) to rapidly increase in number, develop into specialized cells, and enhance their ability to produce and assemble the extracellular matrix. This effect is linked to the release of anabolic morphogens, such as bone morphogenetic proteins, which are essential for the formation, maintenance, and repair of bones and cartilage.

Additionally, PEMF promotes the release of anti-inflammatory cytokines through adenosine receptors A2A and A3, with A2A facilitating blood vessel dilation and regulating immune responses, while A3 is involved in modulating inflammation and protecting tissues from damage. These findings were observed in both lab-based and in vivo studies.

PubMed ID: 29020880

Depression

Several studies have highlighted the efficacy of transcranial pulsed electromagnetic field (tPEMF) stimulation in treating depression.

In a double-blind randomized controlled trial by Martiny et al. (2010), tPEMF therapy significantly improved depression scores in 50 patients with treatment-resistant depression (TRD) over 5 weeks, as measured by the Hamilton Depression Rating Scale-17 (HAMD-17).

Rohan et al. (2013) also conducted a randomized, double-blind, sham-controlled trial, demonstrating that a portable electromagnetic device had an immediate positive effect on depression severity in 63 patients with unipolar or bipolar depression. The active treatment group experienced significantly greater improvements than the sham-treated control group.

Straaso et al. (2014) conducted a dose-remission study without a sham treatment, where 65 TRD patients underwent tPEMF stimulation for 8 weeks. This study found a significant reduction in depression scores, with no difference between one and two daily doses, indicating both regimens were equally effective.

PubMed ID: 27449361

Doxorubicin "The Red Devil"

A 2024 explored how PEMF stimulation could improve the effectiveness of doxorubicin, a drug commonly used to treat various cancers, including breast cancer. The researchers focused on MDA-MB-231, a type of human breast cancer cell, to see if PEMF could enhance doxorubicin's ability to kill cancer cells.

In the experiment, cancer cells were treated with doxorubicin and then exposed to PEMF for 60 minutes, three times a day, over 24 or 48 hours. The results showed that combining doxorubicin with PEMF significantly reduced the number of surviving cancer cells compared to using doxorubicin alone.

The study also revealed that PEMF made doxorubicin more effective by increasing the cancer cells' arrest in a specific phase of their growth cycle, known as the late G2 phase. This was achieved by boosting the activity of certain proteins that stop the cell cycle, leading to more DNA damage in the cancer cells.

PubMed ID: 38925852

Hypoxia

It's important to understand that low oxygen levels in the body, a condition known as hypoxia, can occur during various situations such as stroke, heart attack, or even just when blood flow is restricted to certain areas. When cells are deprived of oxygen, they can become damaged or even die, leading to serious health issues.

In this study, scientists looked at how low-energy electromagnetic fields affect different types of cells in the body. They focused on cells similar to neurons (nerve cells) and microglial cells (immune cells in the brain). Their main goal was to see how these electromagnetic fields might help protect against damage caused by inflammation and lack of oxygen in the cells.

They tested this by exposing the cells to electromagnetic fields and then subjecting them to conditions similar to low oxygen levels for different amounts of time. They found that the electromagnetic fields helped to reduce cell death and prevented cells from undergoing a type of programmed cell death called apoptosis when they were under low oxygen conditions.

Additionally, the electromagnetic fields stopped a protein called HIF-1α, which is involved in responding to low oxygen levels, from becoming active in the cells. They also found that the electromagnetic fields decreased the production of harmful molecules called reactive oxygen species (ROS), which are usually produced when cells are starved of oxygen.

PubMed ID: 27639248

Insomnia

A 4-week study by the University der Bundeswehr München in Germany looked into PEMF devices for insomnia. 101 patients were randomly given either a working device or a placebo. Among those with the active device:

70% complete relief

24% clear improvement

6% slight improvement

The active-treatment group showed significant improvements in sleep latency, interruptions, sleepiness, concentration, and headaches. No adverse effects of treatment were reported.

PubMed ID: 11697020

Muscle Readiness & Responsiveness

This study investigated how Pulsed Electromagnetic Field (PEMF) stimulation affects muscle activity during cycling, focusing on its impact on oxygen supply and muscle performance. 20 semi-professional cyclists participated in the study. They performed a cycling exercise where PEMF stimulation was either active or inactive in a randomized order. The exercise session began with a one-minute warm-up phase of cycling without any load, followed by an increase in power to a personalized workload level for each cyclist.

During the exercise sessions, PEMF loops were placed on specific muscles (vastus medialis and biceps femoris) of the right leg to measure their effects. Electromyographic (EMG) activity, which measures muscle electrical activity, was recorded from these muscles. Additionally, blood lactate levels were measured before and during the exercise to understand the metabolic impact of PEMF stimulation.

The results showed that when PEMF stimulation was active, there was a noticeable increase in muscle activity during the initial warm-up phase of cycling. This increase in muscle activity suggests that PEMF could potentially enhance muscle readiness and responsiveness to exercise. Furthermore, the study found that blood lactate levels were higher during PEMF stimulation sessions. Elevated blood lactate levels typically indicate increased utilization of glucose by muscles during exercise, highlighting PEMF's influence on metabolic processes.

PubMed ID: 10048902

Non-union Bone Fracture

Since 1979, PEMF has been FDA-approved for treating nonunion fractures, which is the body's inability to heal a fracture, making it as one of the earliest recognized applications for PEMF.

One study involved 139 patients with established non-union fractures who received PEMF treatment. Patients who used the device for less than an average of three hours a day had a success rate of 35.7% (5 out of 14), while those who used it for more than three hours daily had an 80% success rate (108 out of 135).

Treatment success remained consistent regardless of factors such as bone length, fracture type (open or closed), duration of non-union (ranging from nine months to ten years), patient age (under or over 60 years), gender, previous treatment history, infection status, fracture gap size (up to 1cm), or weightbearing status.

Patients who averaged more than three hours of PEMF treatment daily and initially achieved healing were clinically and radiographically reassessed four years post-treatment, revealing that 92% maintained a solid union.

PubMed ID: 10147555

Osteoporosis - PEMF vs Alendronate

In a study on postmenopausal osteoporosis (PMO) in southwest China, 44 women were randomly assigned to either alendronate, a commonly used medication for treating postmenopausal osteoporosis, or PEMF treatment.

The main goal was to see how these treatments affected bone density in the spine and hip, as well as vitamin D levels, muscle strength, and balance over 24 weeks.

Results showed no significant difference between the two groups in improving bone density, muscle strength, balance, and vitamin D levels. This suggests that PEMF treatment is as effective as the commonly used medication alendronate for PMO over the 24-week period.

PubMed ID: 23362148

Period Pain - Primary Dysmenorrhea

A total of 40 women aged 20 to 30 with primary dysmenorrhea were selected and randomly divided into two equal groups. Group A received PEMF treatment three times a week for three months, with each session lasting 30 minutes, in addition to standard medical treatment. In contrast, Group B, the control group, received only standard medical treatment, specifically NSAIDs (nonsteroidal anti-inflammatory drugs).

The researchers assessed menstrual distress and pain using a menstrual distress questionnaire and a VAS (visual analog scale) before and after the treatment for both groups.

The findings indicated significant improvements in menstrual distress and pain scores for both groups after the treatment, with the PEMF group showing more favourable outcomes. The VAS scores demonstrated a highly statistically significant difference after treatment, favouring the PEMF group. Similarly, the menstrual distress questionnaire results the menstrual distress questionnaire results also reflected a significant reduction in symptoms for the PEMF group compared to the non the PEMF group.

Journal of Medicine in Scientific Research: Study link

Reduced DOMS

Yonsei University performed a randomized, double-blind, placebo-controlled study to compare the effects of PEMF therapy and sham treatment on DOMS-related variables in elbow flexors at 24, 48, and 72 hours after delayed onset muscle soreness (DOMS) induction exercise.

In total, 30 healthy male college students measured muscle soreness, peak torque, median frequency (MDF), and electromechanical delay (EMD) during isometric contraction at 24, 48, and 72 hours after DOMS induction exercise.

Overall, the application of PEMF was found to be effective in reducing the physiological deficits associated with DOMS, including improved recovery of perceived muscle soreness, MDF, and EMD during isometric contraction, but there was no difference in isometric peak torque generation. This study indicates that PEMF is useful as a modality to reduce DOMS symptoms.

PubMed ID: 24906295

Rheumatoid Arthritis

This study explores the benefits of PEMF therapy in reducing rheumatoid arthritis (RA) symptoms using a collagen-induced arthritis (CIA) mouse model. PEMF, was tested at two frequencies (10 Hz and 75 Hz) on paw inflammation in mice. Results showed that 10 Hz PEMF significantly reduced inflammation, cartilage destruction, and arthritis symptoms.

Histological analysis revealed that PEMF-treated mice showed reduced infiltration of inflammatory cells into tissues, abnormal tissue growth eroding cartilage and bone, and evidence of bone erosion. Proteins in the blood that help regulate immune responses and inflammation showed reduced IL-1β, though other markers like IL-6 and TNF-α were unaffected. However, tissue levels of these cytokines were significantly lower in the joints of treated mice, suggesting that PEMF reduces localized inflammation and preserves joint structure.

Overall, the study suggests that PEMF can help slow RA progression by protecting joint tissues and reducing inflammation, showing promise as a complementary therapy for RA management.

PubMed ID: 36674651

Tinnitus

In a study 58 patients from the Liverpool Tinnitus Association volunteered to take part in a double-blind placebo controlled trial. They applied pulsed electromagnetic stimulation, over the mastoid bone, to see if it caused an improvement in the level of tinnitus in long-standing tinnitus sufferers. At the end of just one week of treatment, each patient noted whether their tinnitus had completely disappeared, was improved, unchanged or made worse by the treatment 45% of the patients who completed the trial were improved by the active device.

PubMed ID: 8877185

Tissue Healing - Oral Mucosa/ Tissue

This study looked at how pulsed electromagnetic fields (PEMF) affect healing in oral tissue using a rat model. PEMF was applied twice daily for 60 minutes, and outcomes were compared over 4 and 7 days.

The key finding was that PEMF significantly accelerated healing. Treated groups showed smaller wound areas, faster epithelialisation, and better tissue formation, alongside reduced inflammation. On a cellular level, there was also an increase in growth factors linked to repair and regeneration.

Overall, this suggests PEMF may support faster and more efficient healing in oral tissue, particularly through reducing inflammation and promoting tissue repair processes.

PubMed ID: 41875106

White Blood Cell Count

The study investigated the effects of pulsed electromagnetic field exposure with different pulse parameters on white blood cells (WBC) and lymphocytes (LYM) in male BALB/c mice. The mice were divided into groups and exposed to PEMF at 100, 1000, and 10000 Hz, with a control group receiving no exposure. Following the exposure, blood samples were collected to measure WBC and LYM levels.

The results showed that PEMF exposure at 100 and 1000 Hz led to significant increases in WBC and LYM compared to the control group. However, no significant changes were observed in these parameters for the group exposed to 10000 Hz. These findings suggest that lower pulse PEMF exposure can induce significant increases in WBC and LYM, whereas higher pulse exposure does not produce the same effect. This indicates that the response of WBC and LYM to PEMF exposure may vary depending on the number of pulses administered.

PubMed ID: 31019981

Systematic Reviews & Meta-Analysis

Back Pain - Pain and Function

This systematic review looked at PEMF stimulation for non-specific low back pain, including 9 randomised controlled trials (420 participants).

The key finding was that over half of the studies showed significant improvements in both pain and physical function, particularly when used alongside conventional therapy. However, results were inconsistent, with some studies showing no significant difference, largely due to variations in protocols.

A key insight is the wide range of intensities used, from 20–1,500 Gauss, with indications that higher intensities tended to produce better outcomes.

Overall, this suggests electromagnetic stimulation can be a useful adjunct for low back pain, especially for improving function, but results depend heavily on treatment parameters and consistency.

PubMed ID: 37999784

Bone Density & Pain - Postmenopausal Osteoporosis Support

This meta-analysis included 19 randomised controlled trials (1,303 patients) with postmenopausal osteoporosis.

The key finding was that PEMF increased bone mineral density (BMD) (particularly in the femur and hip regions) and reduced pain, especially when combined with conventional treatments. It also improved several bone formation markers (e.g. ALP, BSAP, osteocalcin), with no increase in adverse events, supporting both efficacy and safety.

Overall, PEMF showed consistent benefits as a complementary therapy for improving bone health and symptom relief in postmenopausal osteoporosis.

PubMed ID: 35864717

Bone Health - Disease Progression

This review included 7 systematic reviews, with patient numbers ranging from 77 to over 1,000 per review, examining conservative treatments for avascular necrosis (AVN) of the femoral head. PEMF was included in 1 of the reviews.

The key finding was that PEMF helped delay disease progression when used alongside other therapies, rather than as a standalone treatment. While multiple treatment options were assessed, PEMF consistently appeared as a supportive therapy within combination approaches, particularly in early-stage AVN.

PubMed ID: 36777071

Cell Response - Gauss Exposure Parameters

This systematic review and meta-analysis included 92 in vitro studies published between 1999 and 2019, covering 3,249 experimental observations.

The key finding was that PEMF effects in vitro were highly dependent on cell type and exposure settings. Across human cell experiments, only about 51% showed a significant cellular response, so the overall picture was mixed rather than uniformly positive. That said, some cell types appeared more responsive, particularly MG-63 human osteosarcoma cells and bone marrow mesenchymal stem cells, while SaOS-2 osteogenic sarcoma cells and adipose-derived mesenchymal stem cells appeared less sensitive.

The review also found that PEMF was more likely to produce a response when studies used frequencies above 100 Hz, flux densities between 10 Gauss and 100 Gauss, and chronic exposure longer than 10 days. Acute exposure over 24 hours was less likely to show an effect.

Because this was an in vitro review, the outcomes were not clinical outcomes like pain or healing, but cellular responses such as proliferation, differentiation, apoptosis, gene expression, protein expression, calcium signalling, and enzyme activity. So this paper is useful more as a parameter-mapping study than as proof of clinical benefit.

PubMed ID: 34368353

Chronic Back Pain - Symptom Relief

This meta-analysis included 14 randomised controlled trials (618 participants) with low back pain.

The key finding was that PEMF significantly reduced pain, particularly in chronic low back pain, but it did not significantly improve physical function. The benefit was clearer when PEMF was compared with placebo or added to other therapy, while results in acute low back pain were not significant.

Overall, this suggests PEMF is most useful as a pain-relief therapy for chronic low back pain, rather than a treatment for restoring physical function.

PubMed ID: 35077249

Fracture Healing - Clinical Evidence

This systematic review and meta-analysis included 22 RCTs (1,468 participants) with fractures.

The key finding was that PEMF significantly improved healing rates (~79.7% vs 64.3% in controls) and reduced pain, with additional (lower-quality) evidence suggesting it may accelerate healing time. Overall, the evidence was moderate quality for healing and pain, but weaker for healing speed due to high variability between studies.

This supports PEMF as an effective adjunct therapy for fracture healing, particularly for improving the likelihood of union and symptom relief.

PubMed ID: 32495506

Oncology - Safety & Symptom Support

This systematic review looked at whether therapeutic magnetic fields are actually harmful in cancer patients a concern that’s often repeated but rarely backed by clinical data.

Across 3,800+ screened studies, only one randomised controlled trial directly assessed oncological safety outcomes. That study used a 4,000 gauss field at 7.5 Hz alongside chemotherapy, and found no negative impact on disease progression, survival, or treatment response compared to placebo.

Beyond safety, a wider body of evidence explored supportive use during treatment. Studies using lower-frequency protocols (typically ~4–12 Hz, with intensities ranging from millitesla levels up to 4,200 gauss peak-to-peak) reported improvements in things like chemotherapy-induced neuropathy, symptom burden, and overall quality of life.

What’s important here is that none of the clinical studies reported worsened cancer outcomes. The long-standing caution around magnetic field therapy in oncology appears to be driven more by theoretical concerns than clinical evidence.

That said, the review is clear: high-quality trials are still limited, so while current data doesn’t suggest harm, it also isn’t strong enough to define exact clinical guidelines yet. Overall, this paper highlights a key gap magnetic field therapy is widely avoided in oncology, but not because strong evidence shows it should be.

PubMed ID: 31019981

Osteoarthritis Joint Health - Pain & Function

This meta-analysis included 11 randomised controlled trials (614 patients) with osteoarthritis (mainly knee OA).

The key finding was that PEMF significantly reduced pain, improved joint stiffness, and enhanced physical function compared to control treatments. A key insight was that low-frequency PEMF showed stronger and more consistent benefits, particularly for pain and function, while high-frequency results were less consistent.

Overall, this supports PEMF as an effective non-invasive therapy for symptom management in osteoarthritis, especially when using lower frequencies.

PubMed ID: 35586276

Osteoarthritis - Symptom Management

This review included 10 systematic reviews on osteoarthritis (derived from 69 screened studies), covering multiple joints but primarily knee OA.

The key finding was that PEMF consistently reduced pain in the short term and showed improvements in physical function, although results for stiffness and quality of life were more variable. Across the included reviews, around half reported significant positive outcomes, particularly for pain reduction.

A key insight is the extremely wide range of treatment parameters, with intensities ranging from 0.034 gauss to 1,050 gauss, making direct comparisons difficult but highlighting that most clinical use sits within the higher Gauss range.

Overall, this supports PEMF as a safe, non-invasive option for managing osteoarthritis symptoms, particularly pain, with effectiveness depending heavily on protocol.

PubMed ID: 35362792

Osteoarthritis - Pain, Stiffness & Function

This systematic review and meta-analysis included 16 randomized placebo-controlled trials, with 15 studies in the meta-analysis and a total of 1,078 participants. The review found that, compared with placebo, PEMF produced significant improvements in pain, stiffness, and physical function in people with osteoarthritis. Pain showed the strongest effect, and the authors noted this was also clinically significant. Quality of life did not improve significantly overall, although some individual studies suggested possible benefit.

Most of the included studies looked at knee osteoarthritis, with a smaller number on the hand, ankle, and cervical spine. Treatment durations ranged from 10 days to 6 weeks, and follow-up was short-term, up to 12 weeks, so this review mainly supports short-term symptom improvement rather than long-term outcomes.

The review also found that PEMF parameters did not clearly change outcomes, meaning no specific frequency or treatment duration stood out as clearly superior within the available data.

For intensity, the studies were mostly in the low to medium range, ranging from about 0.4 Gauss to 1,050 Gauss. Frequencies ranged from very low up to 6.8 MHz, but most of the more typical OA studies were in the low-frequency range. Because the protocols were very mixed, I would label the overall intensity bracket here as mostly medium, though it included both very low and higher settings.

PubMed ID: 32251502

Knee Osteoarthritis - Joint Function & Pain

This systematic review included 14 randomised controlled trials with 930 participants (482 PEMF, 448 placebo). Overall, PEMF did not show consistent pain reduction across all studies, but when higher-quality trials were isolated, pain improvements became significant at 4 and 8 weeks.

For function, PEMF showed a significant improvement at 8 weeks compared to placebo. No increase in adverse events was found, supporting a good safety profile.

A key nuance here is that results were quality-dependent better-designed studies showed clearer benefits, which strengthens the case for PEMF despite mixed overall findings.

PubMed ID: 22504115

Multiple Sclerosis - Fatigue Reduction

This meta-analysis looked at whether electromagnetic stimulation helps with fatigue in people with multiple sclerosis. It included 7 randomised controlled trials (327 participants) comparing treatment vs sham.

The key finding was a statistically significant reduction in fatigue, although the effect size was modest. There were no significant improvements in quality of life or depressive symptoms, suggesting the effect is specific to fatigue rather than broad systemic changes.

Overall, this supports electromagnetic stimulation as a useful complementary therapy for fatigue in MS, but not a comprehensive treatment for wider symptoms.

PubMed ID: 40540924

Rotator Cuff - Functional Improvement

This meta-analysis looked at electromagnetic stimulation for shoulder impingement syndrome, combining 4 randomised controlled trials (252 participants).

The key finding was a significant improvement in functional capacity, both short-term and long-term, alongside a modest reduction in short-term pain. Long-term pain reduction was not statistically significant, suggesting the main benefit is functional rather than purely analgesic.

A key insight from the subgroup analysis was that higher intensities more than 100 gauss were associated with significant improvements in function, while lower intensities less than 100 gauss showed no meaningful effect.

Overall, this shows electromagnetic stimulation can be effective for improving movement and recovery in shoulder conditions, with intensity playing a critical role in outcomes.

PubMed ID: 40388433

Spinal Fusion - Healing Outcomes

This meta-analysis looked at whether electrical stimulation improves outcomes after spinal surgery, including PEMF. Across multiple studies, the fusion rate was significantly higher in the stimulation group (86.8% vs 73.7% in controls).

Specifically, PEMF showed a 2.6x higher likelihood of successful fusion compared to no stimulation, with similar benefits seen across other electrical stimulation methods. This suggests the effect is consistent across different stimulation types.

Overall, this supports electrical stimulation as an effective adjunct therapy for improving bone healing and fusion after surgery, although protocols and intensities varied between studies.

PubMed ID: 39278993

Wound Healing - Diabetic Skin Wounds

This was a systematic review of 82 preclinical studies on biophysical energies for diabetic wound healing, including 5 PEMF studies. The review was broader than PEMF alone, but the PEMF section was clearly relevant and showed positive findings overall. Across the PEMF studies, wound closure percentage was the main outcome, and the PEMF-treated groups generally showed faster or greater healing than controls. The review also noted improvements in measures linked to tissue repair, including cell proliferation, vascularity, FGF-2 secretion, collagen organisation, tensile strength, myofibroblast production, and mechanical properties of the wound tissue.

For PEMF specifically, the reported protocols were in the medium-intensity range: 20, 50, and 100 Gauss at 25 Hz, plus 80 Gauss at 20 Hz.

One useful nuance from the review is that although all five PEMF studies were presented as supportive overall, 4 of the 5 specifically reported a significant between-group improvement in wound size or wound closure, while one mechanistic study suggested the effect may depend on FGF-2 signalling, because the benefit was not seen in FGF-2 knockout mice.

PubMed ID: 30654555

Country/region